Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Ophthalmic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global ophthalmic drugs market reached a value of US$ 40.47 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 56.25 Billion by 2027, exhibiting a CAGR of 5.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Ophthalmic drugs are medications that are specially designed and administered for the treatment of various eye-related disorders, including color blindness, diabetic macular edema, cytomegalovirus (CMV), and age-related macular degeneration (AMD). These medications can be delivered in the form of an emulsion, ointment, aqueous gels, dendrimers, nanosuspensions, or contact lenses. Ophthalmic drugs are manufactured from neomycin, antibiotics, bacitracin, and polymyxin that aid in mitigating the growth of bacterial infection in the eye. At present, they are commercially available in solid, liquid, and semi-solid formulation types.   

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Ophthalmic Drugs Market Trends:

The increasing prevalence of various eye-related disorders, such as visual impairment, glaucoma, and color blindness, especially amongst the rising geriatric population, is primarily driving the ophthalmic drugs market growth. In line with this, the rising awareness regarding the anti-inflammatory properties of the drug is further facilitating their demand to treat scleritis, cystoid macular edema, and uveitis disorders. Moreover, the extensive fundings and favorable initiatives being undertaken by the governments of several countries to promote the production of effective ophthalmic drugs with novel formulations and combinations are also supporting the market growth.  Besides this, significant technological advancements, including the introduction of gene-drug therapies for diagnosing and treating hereditary ophthalmic, neurovascular retinal, and retinoblastoma disorders, are acting as another growth-inducing factors. Additionally, the easy availability of ophthalmic drugs in eye solutions, drops, capsules, tablets, gels, and ointments forms across several online and offline distribution channels is contributing to the market growth. Other factors, such as significant expansion in the pharmaceutical industry, along with rising research and development (R&D) activities to introduce cost-effective ocular drug delivery systems (ODDS), are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global ophthalmic drugs market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, drug class, indication, dosage form and distribution channel.

Breakup by Type:

  • Prescription Drugs
  • Over-the-counter Drugs
     

Breakup by Drug Class:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Anti-glaucoma
  • Anti-infection
  • Anti-inflammation
  • Anti-allergy
  • Others
     

Breakup by Indication:

  • Dry Eye
  • Glaucoma
  • Infection/Inflammation/Allergy
  • Retinal Disorders
  • Others
     

Breakup by Dosage Form:

  • Liquid Ophthalmic Drug Forms
  • Solid Ophthalmic Drug Forms
  • Semisolid Ophthalmic Drug Forms
  • Multicompartment Drug Delivery Systems
  • Others
     

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Others
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Aerie Pharmaceuticals Inc., Akorn Inc., Alcon, Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd. and Sun Pharmaceutical Industries Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Type, Drug Class, Indication, Dosage Form, Distribution Channel, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AbbVie Inc., Aerie Pharmaceuticals Inc., Akorn Inc., Alcon, Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd. and Sun Pharmaceutical Industries Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global ophthalmic drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global ophthalmic drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the dosage form?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global ophthalmic drugs market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global Ophthalmic Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Type
    6.1    Prescription Drugs
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Over-the-counter Drugs
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Drug Class
    7.1    Anti-glaucoma
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Anti-infection
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Anti-inflammation
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Anti-allergy
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Indication
    8.1    Dry Eye
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Glaucoma
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Infection/Inflammation/Allergy
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Retinal Disorders
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by Dosage Form
    9.1    Liquid Ophthalmic Drug Forms
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Solid Ophthalmic Drug Forms
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Semisolid Ophthalmic Drug Forms
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Multicompartment Drug Delivery Systems
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Others
        9.5.1 Market Trends
        9.5.2 Market Forecast
10    Market Breakup by Distribution Channel
    10.1    Hospital Pharmacies
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Drug Stores
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Online Pharmacies
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4    Others
        10.4.1 Market Trends
        10.4.2 Market Forecast
11    Market Breakup by Region
    11.1    North America
        11.1.1 United States
           11.1.1.1 Market Trends
           11.1.1.2 Market Forecast
        11.1.2 Canada
           11.1.2.1 Market Trends
           11.1.2.2 Market Forecast
    11.2    Asia-Pacific
        11.2.1 China
           11.2.1.1 Market Trends
           11.2.1.2 Market Forecast
        11.2.2 Japan
           11.2.2.1 Market Trends
           11.2.2.2 Market Forecast
        11.2.3 India
           11.2.3.1 Market Trends
           11.2.3.2 Market Forecast
        11.2.4 South Korea
           11.2.4.1 Market Trends
           11.2.4.2 Market Forecast
        11.2.5 Australia
           11.2.5.1 Market Trends
           11.2.5.2 Market Forecast
        11.2.6 Indonesia
           11.2.6.1 Market Trends
           11.2.6.2 Market Forecast
        11.2.7 Others
           11.2.7.1 Market Trends
           11.2.7.2 Market Forecast
    11.3    Europe
        11.3.1 Germany
           11.3.1.1 Market Trends
           11.3.1.2 Market Forecast
        11.3.2 France
           11.3.2.1 Market Trends
           11.3.2.2 Market Forecast
        11.3.3 United Kingdom
           11.3.3.1 Market Trends
           11.3.3.2 Market Forecast
        11.3.4 Italy
           11.3.4.1 Market Trends
           11.3.4.2 Market Forecast
        11.3.5 Spain
           11.3.5.1 Market Trends
           11.3.5.2 Market Forecast
        11.3.6 Russia
           11.3.6.1 Market Trends
           11.3.6.2 Market Forecast
        11.3.7 Others
           11.3.7.1 Market Trends
           11.3.7.2 Market Forecast
    11.4    Latin America
        11.4.1 Brazil
           11.4.1.1 Market Trends
           11.4.1.2 Market Forecast
        11.4.2 Mexico
           11.4.2.1 Market Trends
           11.4.2.2 Market Forecast
        11.4.3 Others
           11.4.3.1 Market Trends
           11.4.3.2 Market Forecast
    11.5    Middle East and Africa
        11.5.1 Market Trends
        11.5.2 Market Breakup by Country
        11.5.3 Market Forecast
12    SWOT Analysis
    12.1    Overview
    12.2    Strengths
    12.3    Weaknesses
    12.4    Opportunities
    12.5    Threats
13    Value Chain Analysis
14    Porters Five Forces Analysis
    14.1    Overview
    14.2    Bargaining Power of Buyers
    14.3    Bargaining Power of Suppliers
    14.4    Degree of Competition
    14.5    Threat of New Entrants
    14.6    Threat of Substitutes
15    Price Analysis
16    Competitive Landscape
    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1    AbbVie Inc.
           16.3.1.1 Company Overview
           16.3.1.2 Product Portfolio
           16.3.1.3 Financials
           16.3.1.4 SWOT Analysis
        16.3.2    Aerie Pharmaceuticals Inc.
           16.3.2.1 Company Overview
           16.3.2.2 Product Portfolio
           16.3.2.3 Financials
        16.3.3    Akorn Inc.
           16.3.3.1 Company Overview
           16.3.3.2 Product Portfolio
        16.3.4    Alcon
           16.3.4.1 Company Overview
           16.3.4.2 Product Portfolio
           16.3.4.3 Financials
        16.3.5    Bausch Health Companies Inc.
           16.3.5.1 Company Overview
           16.3.5.2 Product Portfolio
        16.3.6    Bayer AG
           16.3.6.1 Company Overview
           16.3.6.2 Product Portfolio
           16.3.6.3 Financials
           16.3.6.4 SWOT Analysis
        16.3.7    F. Hoffmann-La Roche AG
           16.3.7.1 Company Overview
           16.3.7.2 Product Portfolio
           16.3.7.3 SWOT Analysis
        16.3.8    Johnson & Johnson
           16.3.8.1 Company Overview
           16.3.8.2 Product Portfolio
           16.3.8.3 Financials
           16.3.8.4 SWOT Analysis
        16.3.9    Merck & Co. Inc.
           16.3.9.1 Company Overview
           16.3.9.2 Product Portfolio
           16.3.9.3 Financials
           16.3.9.4 SWOT Analysis
        16.3.10    Novartis AG
           16.3.10.1 Company Overview
           16.3.10.2 Product Portfolio
           16.3.10.3 Financials
           16.3.10.4 SWOT Analysis
        16.3.11    Regeneron Pharmaceuticals Inc.
           16.3.11.1 Company Overview
           16.3.11.2 Product Portfolio
           16.3.11.3 Financials
           16.3.11.4 SWOT Analysis
        16.3.12    Santen Pharmaceutical Co. Ltd.
           16.3.12.1 Company Overview
           16.3.12.2 Product Portfolio
        16.3.13    Sun Pharmaceutical Industries Ltd.
           16.3.13.1 Company Overview
           16.3.13.2 Product Portfolio

List of Figures

Figure 1: Global: Ophthalmic Drugs Market: Major Drivers and Challenges
Figure 2: Global: Ophthalmic Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Ophthalmic Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Ophthalmic Drugs Market: Breakup by Type (in %), 2021
Figure 5: Global: Ophthalmic Drugs Market: Breakup by Drug Class (in %), 2021
Figure 6: Global: Ophthalmic Drugs Market: Breakup by Indication (in %), 2021
Figure 7: Global: Ophthalmic Drugs Market: Breakup by Dosage Form (in %), 2021
Figure 8: Global: Ophthalmic Drugs Market: Breakup by Distribution Channel (in %), 2021
Figure 9: Global: Ophthalmic Drugs Market: Breakup by Region (in %), 2021
Figure 10: Global: Ophthalmic Drugs (Prescription Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Ophthalmic Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Ophthalmic Drugs (Over-the-counter Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Ophthalmic Drugs (Over-the-counter Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Ophthalmic Drugs (Anti-glaucoma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Ophthalmic Drugs (Anti-glaucoma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Ophthalmic Drugs (Anti-infection) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Ophthalmic Drugs (Anti-infection) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Ophthalmic Drugs (Anti-inflammation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Ophthalmic Drugs (Anti-inflammation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Ophthalmic Drugs (Anti-allergy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Ophthalmic Drugs (Anti-allergy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Ophthalmic Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Ophthalmic Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Ophthalmic Drugs (Dry Eye) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Ophthalmic Drugs (Dry Eye) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Ophthalmic Drugs (Glaucoma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Ophthalmic Drugs (Glaucoma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Ophthalmic Drugs (Infection/Inflammation/Allergy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Ophthalmic Drugs (Infection/Inflammation/Allergy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Ophthalmic Drugs (Retinal Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Ophthalmic Drugs (Retinal Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Ophthalmic Drugs (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Ophthalmic Drugs (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Ophthalmic Drugs (Liquid Ophthalmic Drug Forms) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Ophthalmic Drugs (Liquid Ophthalmic Drug Forms) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Ophthalmic Drugs (Solid Ophthalmic Drug Forms) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Ophthalmic Drugs (Solid Ophthalmic Drug Forms) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Ophthalmic Drugs (Semisolid Ophthalmic Drug Forms) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Ophthalmic Drugs (Semisolid Ophthalmic Drug Forms) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Ophthalmic Drugs (Multicompartment Drug Delivery Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Ophthalmic Drugs (Multicompartment Drug Delivery Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Global: Ophthalmic Drugs (Other Dosage Forms) Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Global: Ophthalmic Drugs (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Global: Ophthalmic Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Global: Ophthalmic Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Global: Ophthalmic Drugs (Drug Stores) Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Global: Ophthalmic Drugs (Drug Stores) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Global: Ophthalmic Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Global: Ophthalmic Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Global: Ophthalmic Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Global: Ophthalmic Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: North America: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: North America: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: United States: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: United States: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Canada: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Canada: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Asia-Pacific: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Asia-Pacific: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: China: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: China: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Japan: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Japan: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: India: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: India: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: South Korea: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: South Korea: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Australia: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Australia: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Indonesia: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Indonesia: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Europe: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Europe: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Germany: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Germany: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: France: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: France: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: United Kingdom: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: United Kingdom: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Italy: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Italy: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Spain: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Spain: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Russia: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Russia: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Others: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: Others: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Latin America: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 91: Latin America: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Brazil: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 93: Brazil: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 94: Mexico: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 95: Mexico: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 96: Others: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 97: Others: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 98: Middle East and Africa: Ophthalmic Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 99: Middle East and Africa: Ophthalmic Drugs Market: Breakup by Country (in %), 2021
Figure 100: Middle East and Africa: Ophthalmic Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 101: Global: Ophthalmic Drugs Industry: SWOT Analysis
Figure 102: Global: Ophthalmic Drugs Industry: Value Chain Analysis
Figure 103: Global: Ophthalmic Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Ophthalmic Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Ophthalmic Drugs Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Ophthalmic Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 4: Global: Ophthalmic Drugs Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 5: Global: Ophthalmic Drugs Market Forecast: Breakup by Dosage Form (in Million US$), 2022-2027
Table 6: Global: Ophthalmic Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 7: Global: Ophthalmic Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 8: Global: Ophthalmic Drugs Market: Competitive Structure
Table 9: Global: Ophthalmic Drugs Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links